• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement.

作者信息

Scully Paul R, Treibel Thomas A, Fontana Marianna, Lloyd Guy, Mullen Michael, Pugliese Francesca, Hartman Neil, Hawkins Philip N, Menezes Leon J, Moon James C

出版信息

J Am Coll Cardiol. 2018 Jan 30;71(4):463-464. doi: 10.1016/j.jacc.2017.11.037.

DOI:10.1016/j.jacc.2017.11.037
PMID:29389364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5780297/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/5780297/63a25da392f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/5780297/63a25da392f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/936a/5780297/63a25da392f2/gr1.jpg

相似文献

1
Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement.接受经导管主动脉瓣置换术患者的心脏淀粉样变性患病率
J Am Coll Cardiol. 2018 Jan 30;71(4):463-464. doi: 10.1016/j.jacc.2017.11.037.
2
Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.同时患有心脏淀粉样变性和主动脉瓣狭窄的患病率和结局：系统评价和荟萃分析。
Hellenic J Cardiol. 2022 Mar-Apr;64:67-76. doi: 10.1016/j.hjc.2021.11.001. Epub 2021 Nov 29.
3
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.接受经导管主动脉瓣植入术患者的双主动脉瓣狭窄与心脏淀粉样变病理的患病率及预后
Eur Heart J. 2020 Aug 1;41(29):2759-2767. doi: 10.1093/eurheartj/ehaa170.
4
Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术患者心脏淀粉样变性的组织学评估。
ESC Heart Fail. 2024 Jun;11(3):1636-1646. doi: 10.1002/ehf2.14709. Epub 2024 Feb 26.
5
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis.经导管主动脉瓣置换术在主动脉瓣狭窄和心脏淀粉样变性中的应用：系统评价和荟萃分析。
ESC Heart Fail. 2022 Oct;9(5):3188-3197. doi: 10.1002/ehf2.13876. Epub 2022 Jun 29.
6
Aortic valve replacement in patients with amyloidosis.淀粉样变性患者的主动脉瓣置换术。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):98-103. doi: 10.1016/j.jtcvs.2017.12.048. Epub 2017 Dec 19.
7
Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It.接受经导管主动脉瓣置换术（TAVR）患者的心脏淀粉样变性：为何我们需要予以关注。
Cardiovasc Revasc Med. 2021 Jan;22:109-114. doi: 10.1016/j.carrev.2020.06.005. Epub 2020 Jun 10.
8
Cardiac Amyloidosis in Patients With Severe Aortic Stenosis: Not a Good Reason to Say No to Transcatheter Aortic Valve Implantation.重度主动脉瓣狭窄患者的心脏淀粉样变性：并非拒绝经导管主动脉瓣植入术的充分理由
Am J Cardiol. 2023 Aug 1;200:144-145. doi: 10.1016/j.amjcard.2023.05.010. Epub 2023 Jun 13.
9
Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis.老年人心房颤动：亚临床孤立性心脏淀粉样变性的作用。
Sci Rep. 2019 Nov 12;9(1):16584. doi: 10.1038/s41598-019-53119-z.
10
Unmasking Transthyretin Cardiac Amyloidosis Following Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后隐匿性转甲状腺素蛋白心脏淀粉样变的揭示
Circ Heart Fail. 2023 Dec;16(12):e010170. doi: 10.1161/CIRCHEARTFAILURE.123.010603. Epub 2023 Sep 28.

引用本文的文献

1
Advances in imaging-based diagnosis, prognosis, and response assessment in cardiac amyloidosis: a comprehensive multimodality review.心脏淀粉样变性基于成像的诊断、预后及反应评估进展：一项综合性多模态综述
Ann Nucl Med. 2025 Aug 25. doi: 10.1007/s12149-025-02092-x.
2
Development of Cardiac Computed Tomography for Evaluation of Aortic Valve Stenosis.用于评估主动脉瓣狭窄的心脏计算机断层扫描技术的发展
Tomography. 2025 May 28;11(6):62. doi: 10.3390/tomography11060062.
3
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation.

本文引用的文献

1
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.揭示老年重度主动脉瓣狭窄行经导管主动脉瓣置换术患者中的转甲状腺素蛋白心脏淀粉样变性及其预测因素。
Eur Heart J. 2017 Oct 7;38(38):2879-2887. doi: 10.1093/eurheartj/ehx350.
2
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.严重钙化性主动脉瓣狭窄中的隐匿性转甲状腺素蛋白心脏淀粉样变：接受外科主动脉瓣置换术患者的患病率及预后
Circ Cardiovasc Imaging. 2016 Aug;9(8). doi: 10.1161/CIRCIMAGING.116.005066.
3
计划接受经导管主动脉瓣植入术的主动脉瓣狭窄患者中的转甲状腺素蛋白淀粉样心肌病。
ESC Heart Fail. 2025 Aug;12(4):2467-2476. doi: 10.1002/ehf2.15258. Epub 2025 Mar 11.
4
Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study.人工智能引导下即时心脏超声心动图对未被充分认识的心肌病的检测：一项多中心研究。
Lancet Digit Health. 2025 Feb;7(2):e113-e123. doi: 10.1016/S2589-7500(24)00249-8.
5
Strain echocardiography predictors in patients with concomitant cardiac amyloidosis and aortic stenosis: a cross-sectional study.伴有心脏淀粉样变性和主动脉瓣狭窄患者的应变超声心动图预测因素：一项横断面研究。
BMC Cardiovasc Disord. 2024 Dec 20;24(1):734. doi: 10.1186/s12872-024-04415-8.
6
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study.主动确诊对转甲状腺素蛋白心脏淀粉样变患病率和表型的性别差异的影响：少数族裔人群心脏淀粉样变核素成像筛查研究
Am J Cardiol. 2025 Feb 15;237:60-64. doi: 10.1016/j.amjcard.2024.11.019. Epub 2024 Nov 23.
7
Epidemiological Changes in Transthyretin Cardiac Amyloidosis: Evidence from In Vivo Data and Autoptic Series.转甲状腺素蛋白心脏淀粉样变性的流行病学变化：来自体内数据和尸检系列的证据。
J Clin Med. 2024 Aug 29;13(17):5140. doi: 10.3390/jcm13175140.
8
Tracking the Preclinical Progression of Transthyretin Amyloid Cardiomyopathy Using Artificial Intelligence-Enabled Electrocardiography and Echocardiography.使用人工智能辅助心电图和超声心动图追踪转甲状腺素蛋白淀粉样心肌病的临床前进展
medRxiv. 2025 Feb 24:2024.08.25.24312556. doi: 10.1101/2024.08.25.24312556.
9
First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia.沙特阿拉伯心脏淀粉样变性临床特征与转归的首次报告。
ESC Heart Fail. 2024 Dec;11(6):4348-4359. doi: 10.1002/ehf2.15045. Epub 2024 Sep 1.
10
Outcomes of Transcatheter Aortic Valve Replacement in Patients With Coexisiting Amyloidosis: Mortality, Stroke, and Readmission.合并淀粉样变性患者经导管主动脉瓣置换术的结局：死亡率、卒中及再入院情况
JACC Adv. 2023 Mar 8;2(2):100255. doi: 10.1016/j.jacadv.2023.100255. eCollection 2023 Mar.
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
4
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
5
Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.老年系统性淀粉样变性影响25%的高龄人群，并与α2-巨球蛋白和tau蛋白的基因变异相关：一项基于人群的尸检研究。
Ann Med. 2008;40(3):232-9. doi: 10.1080/07853890701842988.